Nov 3, 2023, 08:57 AM by

One of the fastest, most secure fiber-optic networks in the world launched its first near-instantaneous transmission and, for the first time ever, outside of a lab setting and across state lines.

Nov 3, 2023, 01:00 AM by User Not Found

Bio-IT World | The synthetic biology landscape has evolved considerably to include new ways of accessing DNA for research and therapeutic development. An important advance is that DNA production is no longer limited to third-party suppliers.

Nov 2, 2023, 09:02 AM by

Nov 2, 2023, 09:02 AM by

Emory Healthcare and DrFirst collaboration aims to assist patients with medication adherence and affordability

Nov 2, 2023, 09:02 AM by

Nov 2, 2023, 09:02 AM by

At Fusion Technology Solutions, we are pleased to introduce ourselves as one of the leading organizations in Clinical Research Courses, Market Research Courses, and IT Courses training institute.

Nov 1, 2023, 09:08 AM by

Nov 1, 2023, 09:08 AM by

JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences

Nov 1, 2023, 01:00 AM by User Not Found

Bio-IT World | Researchers at the University of Western Ontario and Brown University were surprised to discover an “almost identical mechanism” appearing in the blood and placenta of women with preeclampsia as has been previously found in the brains of older individuals with Alzheimer’s disease (AD), traumatic brain injury (TBI), and vascular dementia.

Oct 31, 2023, 01:00 AM by User Not Found

Bio-IT World | In January, Heidi Rehm will take over the leadership of the Global Alliance for Genomics and Health, GA4GH, replacing out-going Chair Ewan Birney. Rehm sat down with Stan Gloss to talk about the mission of GA4GH and share areas of future focus for the latest episode of the Trends from the Trenches podcast.

Oct 30, 2023, 08:53 AM by

Oct 30, 2023, 08:53 AM by

Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S.

Oct 30, 2023, 08:53 AM by

Oct 30, 2023, 08:53 AM by

Oct 27, 2023, 09:25 AM by

BioIVT will be available to discuss its newly expanded, comprehensive portfolio of neuro-related disease and TruNormal® biospecimens at Neuroscience 2023.

Oct 27, 2023, 09:25 AM by

Oct 27, 2023, 09:25 AM by

Oct 27, 2023, 09:25 AM by

Oct 27, 2023, 09:25 AM by

Oct 27, 2023, 09:25 AM by

Phastar Offers Pro Bono Support to Medicines Development for Global Health Supporting medicine development for disadvantaged communities